Cargando…

Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins

Multiplex electrochemical biosensors have been used for eliminating the matrix effect in complex bodily fluids or enabling the detection of two or more bioanalytes, overall resulting in more sensitive assays and accurate diagnostics. Many electrochemical biosensors lack reliable and low-cost multipl...

Descripción completa

Detalles Bibliográficos
Autores principales: Salahandish, Razieh, Haghayegh, Fatemeh, Ayala-Charca, Giancarlo, Hyun, Jae Eun, Khalghollah, Mahmood, Zare, Azam, Far, Behrouz, Berenger, Byron M., Niu, Yan Dong, Ghafar-Zadeh, Ebrahim, Sanati-Nezhad, Amir
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786409/
https://www.ncbi.nlm.nih.gov/pubmed/35114466
http://dx.doi.org/10.1016/j.bios.2022.114018
_version_ 1784639109625544704
author Salahandish, Razieh
Haghayegh, Fatemeh
Ayala-Charca, Giancarlo
Hyun, Jae Eun
Khalghollah, Mahmood
Zare, Azam
Far, Behrouz
Berenger, Byron M.
Niu, Yan Dong
Ghafar-Zadeh, Ebrahim
Sanati-Nezhad, Amir
author_facet Salahandish, Razieh
Haghayegh, Fatemeh
Ayala-Charca, Giancarlo
Hyun, Jae Eun
Khalghollah, Mahmood
Zare, Azam
Far, Behrouz
Berenger, Byron M.
Niu, Yan Dong
Ghafar-Zadeh, Ebrahim
Sanati-Nezhad, Amir
author_sort Salahandish, Razieh
collection PubMed
description Multiplex electrochemical biosensors have been used for eliminating the matrix effect in complex bodily fluids or enabling the detection of two or more bioanalytes, overall resulting in more sensitive assays and accurate diagnostics. Many electrochemical biosensors lack reliable and low-cost multiplexing to meet the requirements of point-of-care detection due to either limited functional biosensors for multi-electrode detection or incompatible readout systems. We developed a new dual electrochemical biosensing unit accompanied by a customized potentiostat to address the unmet need for point-of-care multi-electrode electrochemical biosensing. The two-working electrode system was developed using screen-printing of a carboxyl-rich nanomaterial containing ink, with both working electrodes offering active sites for recognition of bioanalytes. The low-cost bi-potentiostat system (∼$80) was developed and customized specifically to the bi-electrode design and used for rapid, repeatable, and accurate measurement of electrochemical impedance spectroscopy signals from the dual biosensor. This binary electrochemical data acquisition (Bi-ECDAQ) system accurately and selectively detected SARS-CoV-2 Nucleocapsid protein (N-protein) in both spiked samples and clinical nasopharyngeal swab samples of COVID-19 patients within 30 min. The two working electrodes offered the limit of detection of 116 fg/mL and 150 fg/mL, respectively, with the dynamic detection range of 1–10,000 pg/mL and the sensitivity range of 2744–2936 Ω mL/pg.mm(2) for the detection of N-protein. The potentiostat performed comparable or better than commercial Autolab potentiostats while it is significantly lower cost. The open-source Bi-ECDAQ presents a customizable and flexible approach towards addressing the need for rapid and accurate point-of-care electrochemical biosensors for the rapid detection of various diseases.
format Online
Article
Text
id pubmed-8786409
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-87864092022-01-25 Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins Salahandish, Razieh Haghayegh, Fatemeh Ayala-Charca, Giancarlo Hyun, Jae Eun Khalghollah, Mahmood Zare, Azam Far, Behrouz Berenger, Byron M. Niu, Yan Dong Ghafar-Zadeh, Ebrahim Sanati-Nezhad, Amir Biosens Bioelectron Article Multiplex electrochemical biosensors have been used for eliminating the matrix effect in complex bodily fluids or enabling the detection of two or more bioanalytes, overall resulting in more sensitive assays and accurate diagnostics. Many electrochemical biosensors lack reliable and low-cost multiplexing to meet the requirements of point-of-care detection due to either limited functional biosensors for multi-electrode detection or incompatible readout systems. We developed a new dual electrochemical biosensing unit accompanied by a customized potentiostat to address the unmet need for point-of-care multi-electrode electrochemical biosensing. The two-working electrode system was developed using screen-printing of a carboxyl-rich nanomaterial containing ink, with both working electrodes offering active sites for recognition of bioanalytes. The low-cost bi-potentiostat system (∼$80) was developed and customized specifically to the bi-electrode design and used for rapid, repeatable, and accurate measurement of electrochemical impedance spectroscopy signals from the dual biosensor. This binary electrochemical data acquisition (Bi-ECDAQ) system accurately and selectively detected SARS-CoV-2 Nucleocapsid protein (N-protein) in both spiked samples and clinical nasopharyngeal swab samples of COVID-19 patients within 30 min. The two working electrodes offered the limit of detection of 116 fg/mL and 150 fg/mL, respectively, with the dynamic detection range of 1–10,000 pg/mL and the sensitivity range of 2744–2936 Ω mL/pg.mm(2) for the detection of N-protein. The potentiostat performed comparable or better than commercial Autolab potentiostats while it is significantly lower cost. The open-source Bi-ECDAQ presents a customizable and flexible approach towards addressing the need for rapid and accurate point-of-care electrochemical biosensors for the rapid detection of various diseases. Elsevier B.V. 2022-05-01 2022-01-25 /pmc/articles/PMC8786409/ /pubmed/35114466 http://dx.doi.org/10.1016/j.bios.2022.114018 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Salahandish, Razieh
Haghayegh, Fatemeh
Ayala-Charca, Giancarlo
Hyun, Jae Eun
Khalghollah, Mahmood
Zare, Azam
Far, Behrouz
Berenger, Byron M.
Niu, Yan Dong
Ghafar-Zadeh, Ebrahim
Sanati-Nezhad, Amir
Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins
title Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins
title_full Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins
title_fullStr Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins
title_full_unstemmed Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins
title_short Bi-ECDAQ: An electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of SARS-CoV-2 Nucleocapsid proteins
title_sort bi-ecdaq: an electrochemical dual-immuno-biosensor accompanied by a customized bi-potentiostat for clinical detection of sars-cov-2 nucleocapsid proteins
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8786409/
https://www.ncbi.nlm.nih.gov/pubmed/35114466
http://dx.doi.org/10.1016/j.bios.2022.114018
work_keys_str_mv AT salahandishrazieh biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT haghayeghfatemeh biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT ayalacharcagiancarlo biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT hyunjaeeun biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT khalghollahmahmood biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT zareazam biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT farbehrouz biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT berengerbyronm biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT niuyandong biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT ghafarzadehebrahim biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins
AT sanatinezhadamir biecdaqanelectrochemicaldualimmunobiosensoraccompaniedbyacustomizedbipotentiostatforclinicaldetectionofsarscov2nucleocapsidproteins